Provided by
| Consensus (mean) in EUR million | FY 2024 | FY 2025 | FY 2026 E | FY 2027 E | FY 2028 E |
|---|---|---|---|---|---|
| Orders received | 5,837 | 5,216 | 4,978 | 5,408 | 5,726 |
| - Biomaterial Solutions and Services | 4,392.0 | 3,716.0 | 3,346.2 | 3,570.0 | 3,797.6 |
| - Process Performance Solutions | 1,446.0 | 1,500.0 | 1,631.6 | 1,838.1 | 1,928.4 |
| Net sales | 5,359 | 5,197 | 5,343 | 5,446 | 5,683 |
| - Biomaterial Solutions and Services | 3,922.0 | 3,716.0 | 3,739.0 | 3,612.0 | 3,728.3 |
| - Process Performance Solutions | 1,437.0 | 1,481.0 | 1,615.1 | 1,813.4 | 1,898.6 |
| Comparable EBITA | 609 | 620 | 629 | 684 | 740 |
| - Biomaterial Solutions and Services | 403.0 | 381.0 | 368.4 | 385.3 | 417.1 |
| - Process Performance Solutions | 255.0 | 290.0 | 312.8 | 348.3 | 370.1 |
| Comparable EBITA Margin (%) | 11.4% | 11.9% | 11.8% | 12.6% | 13.0% |
| - Biomaterial Solns. and Servs. | 10.3% | 10.3% | 9.9% | 10.7% | 11.2% |
| - Process Perf. Solns. | 17.7% | 19.6% | 19.4% | 19.2% | 19.5% |
| Reported EPS | 1.52 | 1.52 | 1.77 | 2.15 | 2.43 |
| Dividend per share | 1.35 | 1.35 | 1.41 | 1.49 | 1.56 |